Cai G - Search Results

1

Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation.

Cai G, Ma X, Chen B, Huang Y, Liu S, Yang H, Zou W. Cai G, et al. Tumour Biol. 2016 Sep;37(9):11883-11891. doi: 10.1007/s13277-016-5038-6. Epub 2016 Apr 8. Tumour Biol. 2016. PMID: 27059733

2

Hepatitis B X-interacting protein promotes cisplatin resistance and regulates CD147 via Sp1 in ovarian cancer.

Zou W, Ma X, Yang H, Hua W, Chen B, Cai G. Zou W, et al. Among authors: cai g. Exp Biol Med (Maywood). 2017 Mar;242(5):497-504. doi: 10.1177/1535370216685007. Epub 2017 Jan 5. Exp Biol Med (Maywood). 2017. PMID: 28056551 Free PMC article.

3

MicroRNA-145 Negatively Regulates Cell Proliferation Through Targeting IRS1 in Isolated Ovarian Granulosa Cells From Patients With Polycystic Ovary Syndrome.

Cai G, Ma X, Chen B, Huang Y, Liu S, Yang H, Zou W. Cai G, et al. Reprod Sci. 2017 Jun;24(6):902-910. doi: 10.1177/1933719116673197. Epub 2016 Oct 30. Reprod Sci. 2017. PMID: 27799458

4

MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway.

Xu J, Ma X, Yang H, Zhang J, Cai G, Yao N. Xu J, et al. Among authors: cai g. Chem Pharm Bull (Tokyo). 2021;69(4):325-332. doi: 10.1248/cpb.c20-00600. Chem Pharm Bull (Tokyo). 2021. PMID: 33790078 Free article.

5

Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis.

Cai G, Ma X, Zou W, Huang Y, Zhang J, Wang D, Chen B. Cai G, et al. Gene. 2014 Aug 1;546(1):117-23. doi: 10.1016/j.gene.2013.07.049. Epub 2013 Aug 7. Gene. 2014. PMID: 23933413

6

Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway.

Zou W, Ma X, Hua W, Chen B, Cai G. Zou W, et al. Among authors: cai g. Oncol Rep. 2015 Dec;34(6):3256-63. doi: 10.3892/or.2015.4320. Oncol Rep. 2015. PMID: 26503358

7

BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity.

Zou W, Ma X, Hua W, Chen B, Huang Y, Wang D, Cai G. Zou W, et al. Among authors: cai g. Oncol Lett. 2016 Jan;11(1):551-558. doi: 10.3892/ol.2015.3963. Epub 2015 Nov 24. Oncol Lett. 2016. PMID: 26870246 Free PMC article.

8

BRIP1 variations analysis reveals their relative importance as genetic susceptibility factor for cervical cancer.

Ma XD, Cai GQ, Zou W, Huang YH, Zhang JR, Wang DT, Chen BL. Ma XD, et al. Among authors: cai gq. Biochem Biophys Res Commun. 2013 Apr 5;433(2):232-6. doi: 10.1016/j.bbrc.2013.02.089. Epub 2013 Mar 7. Biochem Biophys Res Commun. 2013. PMID: 23473757

9

First evidence for the contribution of the genetic variations of BRCA1-interacting protein 1 (BRIP1) to the genetic susceptibility of cervical cancer.

Ma XD, Cai GQ, Zou W, Huang YH, Zhang JR, Wang DT, Chen BL. Ma XD, et al. Among authors: cai gq. Gene. 2013 Jul 25;524(2):208-13. doi: 10.1016/j.gene.2013.04.025. Epub 2013 May 1. Gene. 2013. PMID: 23644138

10

Phosphorylation of glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells.

Cai G, Wang J, Xin X, Ke Z, Luo J. Cai G, et al. Int J Oncol. 2007 Sep;31(3):657-62. Int J Oncol. 2007. PMID: 17671694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,442 results

Search Page

Filters